Positron emission tomography (PET) is a valuable imaging in evaluating many malignancies. There are various molecular imaging tracers that are currently being utilized with prostate cancer (PC). Several PET agents imaging different molecular processes in PC have reached the clinic. While all of these agents have demonstrated an advantage over conventional imaging, there are considerable differences in the performance of each in staging newly diagnosed PC. In this article, we review the current updates available of different PET tracers, with a strong focus on the emerging role of prostate-specific membrane antigen PET in the management of newly diagnosed PC.

中文翻译：

---

新诊断的前列腺癌的分子成像。

正电子发射断层扫描（PET）是评估许多恶性肿瘤的有价值的影像。当前有多种分子成像示踪剂正在与前列腺癌（PC）一起使用。几种在PC中对不同分子过程进行成像的PET试剂已进入临床。尽管所有这些试剂均已证明优于常规成像，但在分期新诊断的PC方面，每种试剂的性能存在很大差异。在本文中，我们回顾了不同PET示踪剂的最新更新，重点关注前列腺特异性膜抗原PET在新诊断PC的管理中的新兴作用。